Frontier
Copyright ©The Author(s) 2021.
World J Gastroenterol. Dec 28, 2021; 27(48): 8216-8226
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8216
Figure 2
Figure 2 Potential benefits of combining local ablative therapies with immune checkpoint inhibitors and anti-vascular therapies. IL-12: Interleukin-12.